Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-32457700

ABSTRACT

Background: Carney complex (CNC) is a rare multiple endocrine neoplasia syndrome with autosomal dominant inheritance. Affected individuals present with mucocutaneous lentigines/blue nevi, cardiac and noncardiac myxomatous tumors, and multiple endocrine tumors. Mutations in PRKAR1A have been identified as genetic cause of the disease. Here, we report on pregnancy, delivery and puerperium in a woman with genetically confirmed CNC and her newborn. Case: The 31 year-old gravida 5 para 1 with CNC was referred at 26 weeks of gestation. Adrenocorticotropin-independent hypercortisolism, hyperglycemia, hypertension, low serum potassium, and osteoporotic fractures were present. Treatment with metyrapone, a reversible 11-beta-hydroxylase inhibitor, was initiated. The maternal condition improved, and a 5 weeks' pregnancy prolongation could be achieved. Elective repeat cesarean section was performed at 31 weeks of gestation for recurrent vaginal bleeding. The neonate developed transient hyponatremia necessitating hydrocortisone substitution for 2 weeks. Conclusion: In our case, treatment of CNC-associated hypercortisolism in pregnancy with metyrapone was effective. Maternal side effects did not occur. The newborn presented with transient hypocortisolism most likely due to transplacental drug effect. Our case illustrates that the treatment of rare diseases in pregnancy represents a challenge requiring interdisciplinary team work.


Subject(s)
Antimetabolites/therapeutic use , Carney Complex/pathology , Cesarean Section/methods , Cushing Syndrome/physiopathology , Metyrapone/therapeutic use , Pregnancy Complications, Neoplastic/pathology , Adult , Carney Complex/drug therapy , Carney Complex/surgery , Female , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Neoplastic/drug therapy , Pregnancy Complications, Neoplastic/surgery , Pregnancy Outcome
2.
Toxicol Appl Pharmacol ; 239(1): 116-23, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19501113

ABSTRACT

The phthalate ester mono-(2-ethylhexyl) phthalate (MEHP) is the active metabolite of di-(2-ethylhexyl) phthalate, a high-production-volume chemical used as a plasticizer and solvent in numerous consumer products. MEHP has been demonstrated to be a reproductive toxicant in rodents decreasing estradiol and progesterone production in preovulatory granulosa cells. In the present study, we examined the effect of MEHP on steroid production of human granulosa-lutein (GL) cells. Human GL cells collected from women undergoing in vitro fertilization were cultured in medium containing FSH, hCG and 8-Br-cAMP, respectively, together with various concentrations of MEHP (0-500 micromol L(-1)). After incubation for 48 h estradiol and progesterone were assayed in the spent culture medium. Furthermore, aromatase activity and mRNA levels of GL cells were determined. Basal as well as FSH-, hCG- and 8-Br-cAMP-stimulated estradiol production of GL cells was suppressed by MEHP in a dose-dependent manner (IC(50)=105 micromol L(-1), 138 micromol L(-1), 49 micromol L(-1) and 78 micromol L(-1)). Furthermore aromatase activity and mRNA levels were reduced in GL cells cultured with MEHP. In contrast, MEHP did not alter the production of progesterone up to a concentration of 167 micromol L(-1). The present data indicate that MEHP is a specific inhibitor of estradiol production in human GL cells with a post-cAMP site of action. The inhibition of estradiol production obviously results from a reduction of aromatase activity on the transcript level. As the in vitro effective doses of MEHP are within the range of real environmental exposure levels an inhibitory effect on estrogen production in vivo seems to be possible.


Subject(s)
Diethylhexyl Phthalate/analogs & derivatives , Endocrine Disruptors/toxicity , Estradiol/biosynthesis , Granulosa Cells/drug effects , Progesterone/biosynthesis , Aromatase/biosynthesis , Aromatase/metabolism , Cell Culture Techniques , Cell Survival/drug effects , Cells, Cultured , Diethylhexyl Phthalate/toxicity , Female , Granulosa Cells/enzymology , Granulosa Cells/metabolism , Humans , Microsomes/drug effects , Microsomes/enzymology , Microsomes/metabolism
3.
Sci Total Environ ; 390(1): 45-52, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18022676

ABSTRACT

In this study, the actual risk of DDT pollution to two European human populations was assessed by analysing DDT residues in the diet, which is the main route of pollution for man, and in the blood and placenta, which are components affecting organs and new generations, respectively. The Gdansk region was selected as representative of areas subjected to a recent DDT ban in Europe, while a rural area in Western Germany was considered representative of European regions where DDT use and production ceased many years ago. The results of three food series of food sampling carried out with market basket methods during 2003 showed that pp'DDE, which is by far the main constituent of DDT residues, was present in foods of animal origin and in cereals at rather high concentrations in both countries, and that a risk for human health cannot be excluded. The total daily intake was higher in Poland than in Germany, and agrees with the finding that body tissues, on the average, are more polluted in donors from Poland than those from Germany.


Subject(s)
Dichlorodiphenyl Dichloroethylene/analysis , Dichlorodiphenyl Dichloroethylene/blood , Environmental Pollutants/analysis , Environmental Pollutants/blood , Food Contamination/analysis , Adolescent , Adult , Beverages/analysis , Diet , Environmental Monitoring , Female , Food Analysis , Germany , Humans , Male , Middle Aged , Placenta/chemistry , Poland
SELECTION OF CITATIONS
SEARCH DETAIL
...